↓ Skip to main content

The Impact of Clinical Factors, ALK Fusion Variants, and BIM Polymorphism on Crizotinib-Treated Advanced EML4–ALK Rearranged Non-small Cell Lung Cancer

Overview of attention for article published in Frontiers in oncology, September 2019
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Good Attention Score compared to outputs of the same age and source (73rd percentile)

Mentioned by

twitter
4 X users
reddit
1 Redditor

Citations

dimensions_citation
9 Dimensions

Readers on

mendeley
9 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The Impact of Clinical Factors, ALK Fusion Variants, and BIM Polymorphism on Crizotinib-Treated Advanced EML4–ALK Rearranged Non-small Cell Lung Cancer
Published in
Frontiers in oncology, September 2019
DOI 10.3389/fonc.2019.00880
Pubmed ID
Authors

Yen-Ting Lin, Yi-Nan Liu, Jin-Yuan Shih

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 9 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 9 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 4 44%
Lecturer 2 22%
Other 2 22%
Unknown 1 11%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 3 33%
Engineering 2 22%
Medicine and Dentistry 2 22%
Nursing and Health Professions 1 11%
Unknown 1 11%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 October 2021.
All research outputs
#15,174,829
of 25,774,185 outputs
Outputs from Frontiers in oncology
#4,244
of 22,796 outputs
Outputs of similar age
#181,718
of 357,139 outputs
Outputs of similar age from Frontiers in oncology
#105
of 413 outputs
Altmetric has tracked 25,774,185 research outputs across all sources so far. This one is in the 40th percentile – i.e., 40% of other outputs scored the same or lower than it.
So far Altmetric has tracked 22,796 research outputs from this source. They receive a mean Attention Score of 3.1. This one has done well, scoring higher than 80% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 357,139 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 48th percentile – i.e., 48% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 413 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 73% of its contemporaries.